Kevin D Bunker Net Worth & Insider Trades

Kevin D Bunker - Chief Scientific Officer, Zentalis Pharmaceuticals, Inc

As of October 3, 2022

What is Kevin D Bunker's Net Worth?

The current estimated net worth of Zentalis Pharmaceuticals, Inc's Chief Scientific Officer, Kevin D Bunker, is estimated to be about $33.25M . Kevin D Bunker owns about 95,350 units of Zentalis Pharmaceuticals, Inc common stock. In the last 2 years at Zentalis Pharmaceuticals, Inc, Kevin D Bunker has sold an estimated value of $18.04M worth.

What is Kevin D Bunker's Past Insider Trading?

Kevin D Bunker's largest purchase order was 101,395 units , worth over $6.3K on November 25, 2020. Kevin D Bunker's largest sale order was 36,587 units , worth over $1.82M on January 6, 2021. In total, Kevin D Bunker has made about 36 transactions over 2 years of their time at Zentalis Pharmaceuticals, Inc. Kevin D Bunker usually trades in April, March and July, with the busiest year in 2021. The most recent transaction was a sale order of 5,000 units , worth over $150K on August 12, 2022.

Kevin D Bunker

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Kevin D Bunker's Salary in 2020?

As Chief Scientific Officer of Zentalis Pharmaceuticals, Inc, Kevin D Bunker has a total base salary of $428,771 . Kevin D Bunker received compensation valued at about $6,273,594 in 2020 after becoming Chief Scientific Officer. The vast majority of their compensation came in the form of stock awards of $2,580,864 , option awards of $2,993,235 , other earnings, plans or compensations of $179,550 , and other compensation of $91,174 .

What is Kevin D Bunker's' Mailing Address?

  • Mailing address is C/o Zentalis Pharmaceuticals, Inc. 530 Seventh Avenue, Suite 2201 New York NY 10018 NY

Zentalis Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Anthony Sun, M.D. 2020 $561,232 - $8,100,645 $5,986,469 $287,375 $108,678 $15,044,399
Anthony Sun, M.D. 2019 $455,091 - - $918,000 $204,971 - $1,577,882
Kevin Bunker, Ph.D. 2020 $428,771 - $2,580,864 $2,993,235 $179,550 $91,174 $6,273,594
Kevin Bunker, Ph.D. 2019 $360,024 - - $275,400 $144,010 - $779,434
Alexis M. Pinto 2020 $136,923 - - $6,234,468 $152,000 $10,511 $6,533,902
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1725160/000172516021000099/proxystatement-2021.htm

What are Zentalis Pharmaceuticals, Inc's Past Insider Trades?

Zentalis Pharmaceuticals, Inc's most recent insider trade came on January 18, 2023 by Cam Gallagher who sold 10,000 units worth $241.51K . In the last 3 years, insiders at Zentalis Pharmaceuticals, Inc have sold an estimated value of $107.24M and bought an estimated value of $15.77M worth of shares. Insider trading is most common in February, with the busiest year in 2021. The most active traders at the company are Cam Gallagher, President,  Kevin D Bunker, Chief Scientific Officer,  and Anthony ySun, President & CEO .

Zentalis Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1